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Cortical pathology, callosal atrophy and axonal loss are substrates of progression in multiple sclerosis (MS).
Here we describe cortical, periventricular subcortical lesions and callosal demyelination in relapsing^remitting
experimental autoimmune encephalomyelitis in SJL mice that are similar to lesions found in MS. Unlike the
T-cell infiltrates that peak during acute disease, we found that microglia activation persists through the chronic
disease phase. Microglia activation correlated with abnormal phosphorylation of neurofilaments in the cortex
and stripping of synaptic proteins in cortical callosal projecting neurons. There was significant impairment
of retrograde labeling of NeuN-positive callosal projecting neurons and reduction in the labelling of their
transcallosal axons. These data demonstrate a novel paradigm of cortical and callosal neuropathology in
a mouse model of MS, perpetuated by innate immunity. These features closely mimic the periventricular and
cortical pathology described in MS patients and establish a model that could be useful to study mechanisms of
progression in MS.
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Introduction
A key feature of progression in multiple sclerosis (MS) is
the development of widespread neuronal dysfunction in
cortical and subcortical areas (Imitola et al., 2006), together
with lesions characterized by demyelination, inflammation
and axonal loss (Lassmann, 1998). Experimental autoim-
mune encephalomyelitis (EAE) is the most commonly used
animal model for MS, but murine EAE models are thought
to have predominant spinal cord pathology and to rarely
affect the brain (Waksman and Adams, 1962). Cortical
lesions mimicking those in MS have previously been
demonstrated in the marmoset EAE model (Villoslada
et al., 2000; Pomeroy et al., 2005; Merkler, Boscke et al.,
2006), but the high cost and demanding requirements for
animal husbandry as well as the absence of knockout or
transgenic animals make the availability of a rodent model
of crucial interest. Cortical lesions can be induced in
Lewis rats by cortical injection of proinflammatory
cytokines (Merkler, Ernsting et al., 2006), but these lesions
are reversible and the model is not suitable for investigating
questions about the chronic phase of MS (Steinman, 2001).
MS starts as a focal inflammatory disease of the CNS
associated with demyelinating plaques (Ge et al., 2005),
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but progression of the disease is thought to be related
to chronic activation of parenchymal and perivascular
microglia (Kutzelnigg et al., 2005). This is supported by
data from the EAE model where inactivation of microglia
inhibits EAE (Heppner et al., 2005). Microglia-mediated
neurotoxicity has been well described in vitro, where
activated microglia trigger the production and release of
neurotoxic molecules and pro-inflammatory cytokines that
lead to severe neuronal dysfunction through axonal loss
(Cardona et al., 2006; Skaper et al., 2006). In vivo neuronal
toxicity with synaptic dysfunction during EAE has been
correlated with the appearance of inflammatory infiltrates
and activated microglia (Zhu et al., 2003; Marques et al.,
2006). The mechanism of synaptic dysfunction is thought
to be related to microglia separating pre- and post-synaptic
nerve terminals (Blinzinger and Kreutzberg, 1968). In MS
brain, activated microglia were found closely apposed
and ensheathing apical dendrites, neurites and neuronal
perikarya, and in association with transected axons and
neuritic ovoids (Peterson et al., 2001).
Cortical pathology and callosal atrophy are associated
with progression of MS (Filippi et al., 2003; Kutzelnigg
et al., 2005; Martola et al., 2006). Callosal projection
neurons located primarily in layers II/III, V and VII in
adult neocortex connect homotopic areas from the two
cerebral hemispheres through the corpus callosum, which
has a central role in inter-hemispheric communication
(Mitchell and Macklis, 2005; Martola et al., 2006). Callosal
projection neurons are thought to be important for motor
coordination and as well as cognitive processes (Rouiller
et al., 1994; Hampel et al., 2002), both of which are
impaired in chronic progressive MS.
We used a relapsing–remitting EAE model to investigate
neuronal dysfunction of cortical callosal projecting pathways
in relation to activated microglia. The model shows features
that resemble some of the periventricular and cortical
pathology described in MS patients. We also demonstrate
a novel paradigm of cortical and callosal neuropathology
affecting callosal projection neurons by activated microglia.
These data establish a murine model that could be useful for
investigating the pathogenesis of progression and potential
therapeutic approaches for chronic MS.
Materials and methods
Animals
Sixty female SJL/J mice were purchased from Jackson Laboratories
Inc. (Bar Harbor, ME) and used at 6–8 weeks of age. Mice were
housed 4/cage and maintained on a 12-h light/dark cycle with
food and water ad libitum. Upon arrival, mice were randomly
assigned to experimental groups, followed by an acclimation
period of at least 3 days prior to any experiment.
EAE induction
SJL/J mice were immunized subcutaneously in two sites (left
and right flank) with 150 mg of PLP139-151 (New England
Peptide LLC, Gardner, MA) emulsified in complete Freund’s
adjuvant (CFA, Sigma Aldrich, Saint Louis, MO) containing
200 mg Mycobacterium Tuberculosis (Difco Laboratories, Detroit,
MI). Mice received 200 ng pertussis toxin (PT, List Biological
Laboratories Inc., Campbell, CA) in 0.2ml PBS (Lonza,
Walkersville, MD) intraperitoneally (ip) at the time of immuniza-
tion and 48 h later. Control mice were immunized with CFA
followed by PT. Mice were scored daily for neurological signs as
follows: 0, no disease; 1, loss of tail tone; 1.5, poor righting ability;
2, hind limb weakness; 3, hind limb paralysis; 4, scale 3 plus
forelimb weakness; 5, moribund.
Criteria for selection of time points
The mice were sacrificed at different time points and divided into
four groups depending on the course of disease and clinical score.
Defining the time points was not based on the number of days but
rather on the course of the disease in individual animals. Acute
phase (around 17 days post immunization, dpi) when animals
reach a minimum clinical score of 1.5; first remission (around
32 dpi) with a maximum clinical score of 1 after the acute phase;
late relapse (between 90–100 dpi) where animals have to reach
a minimum clinical score of 1.5; late remission (between 90
and 100 dpi) where the clinical score has to drop back down to
a maximum of 1 after two relapsing phases.
Tissue processing
At the appropriate time points the mice were deeply anaesthetized
in a CO2 chamber and transcardially perfused with cold PBS
followed by 4% cold paraformaldehyde solution (PFA, Electron
Micoscopy Sciences, Hatfield, PA) in PBS. Brains were removed
and post-fixed in PFA for 48 h.
Histology
The brains were embedded in paraffin and sliced into 2-mm-thick
coronal sections and stained using haematoxylin and eosin (H&E)
for infiltrating cells, Luxol Fast Blue (LFB) for demyelination
or Bielschowsky stain for axonal damage.
Histological evaluation
Number of inflammatory foci, identified as perivascular clusters
containing at least 20 mononuclear cells were quantified. The
mean number of foci was calculated by averaging the counts from
eight sections (four consecutive sections at bregma 0.0 and four
consecutive sections at bregma 0.02, Franklin and Paxinos, 1997)
according to their location; leukocortical (involving both white
matter and adjacent cortical grey matter), intracortical (entirely
within cortex) or subpial. Areas with loss of LFB parenchymal
staining indicative of demyelination or loss of Bielschowsky
staining indicative of axonal loss were compared with similar
areas in age-matched controls. The tissue damage in the white
matter lesions was graded as normal (grade 0), disarrangement of
the nerve fibres (grade 1), the formation of marked vacuoles
(grade 2) and the disappearance of myelinated fibres (grade 3) as
previously described (Wakita et al., 1994).
FACS analysis of CNS isolated cells
Mice were deeply anaesthetized in a CO2 chamber and
transcardially perfused with 30ml PBS. The corpus callosum
and cortical tissue was dissected from a 2mm block from
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the forebrain, minced in a 70 mm strainer, and collected in
HANKS media (Invitrogen, Eugene, OR) containing 5% fetal
bovine serum (Invitrogen) and 0.05% NaN3 (Sigma Aldrich). The
cells were enzymatically dissociated in HBSS (Lonza) containing
10mM HEPES (Lonza) and 2mM EDTA (Sigma Aldrich) for 1 h
at 4C. Cells were then washed and resuspended in 37% Percoll
(Amersham Biosciences Corporation, Piscataway, NJ) and cen-
trifuged for 10min at 500 g to separate cells from myelin. Cells
were labelled directly with fluorescent antibodies (all from BD
Biosciences, San Jose, CA) for 30min for anti-CD4-FITC (1:100),
anti-CD8-PE (1:100), anti-CD45-PerCP-Cy5 (1:100) and anti-
CD11b-APC (1:100), washed three times and fixed in 1% PFA
for 10min, and analysed by a four-colour flow cytometer on a
FACS-Calibur (Becton Dickinson, Mountain View, CA). The data
was analysed using FlowJo 3.7.1 software program.
Immunohistochemistry
Brains were placed in 30% sucrose for at least 24 h for
cryoprotection. Coronal blocks of brain tissue from bregma 2
to +2mm were frozen in cryo-protective O.C.T.-solution (Sakura
Finetek, Torrance, CA) at 80C. The tissue was cut into floating
sections of 40 mm thickness on a freezing microtome. Floating
sections were blocked with 8% horse serum for 1 h and incubated
overnight with mouse anti-NeuN antibody (1:100, Chemicon,
Temecula, CA), rat anti-CD4 (1:100, BD Biosciences), rat anti-
CD8 (1:100, BD Biosciences) and rabbit anti-activated Caspase-3
antibody (1:250, BD Biosciences) or rat anti-CD11b (1:20, BD
Biosciences) and one of the following antibodies: rabbit
anti-CTFG antibody (1:500, Abcam Inc., Cambridge, MA), rat
anti-Ctip2 antibody (1:500, Abcam Inc.), goat anti-Cux-2 anti-
body (1:10, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit
anti-MeCP2 antibody (1:500, Affinity Bioreagents, Golden, CO),
mouse anti-SMI-32 (non-phosphorylated neurofilaments) anti-
body (1:250 Sternberger Monoclonals Inc., Lutherville, MD) or
mouse anti-MBP antibody (1:2000, Sternberger Monoclonals Inc.).
Sagittal brain sections were stained for mouse anti-b-tubulin III
antibody (1:100 Stem cells Technologies). Sections were rinsed and
incubated for 1 h with the appropriate Alexa Flour 488 and 594
secondary antibodies (1:500, Molecular Probes, Eugene, OR) and
mounted on microscope slides and cover-slipped. Negative control
sections for each animal received identical preparations for
immunostaining, except that primary antibodies were omitted.
TUNEL staining was performed according to manufacturer’s
instructions using an In Situ Cell Death detection kit from Roche
Applied Systems (Roche Applied Sciences, Mannheim, Germany).
Briefly, deparaffinized sections were incubated for 15min at 37C
in a humidified chamber in Proteinase K solution (20 mg/ml in
10mM Tris pH 8.0, Roche Applied Sciences). After a washing
step, sections were incubated with the enzyme solution diluted
1:10 in labelling solution. For double labelling with NeuN and
TUNEL, the sections were immunostained first and fixed with 4%
PFA/PBS for 15min at RT. After a washing step, sections were
stained for TUNEL as described earlier omitting the permeabili-
zation with proteinase K.
Confocal analysis
Regions of interest were analysed with a confocal microscope
(LSM 510 Laser Scanning Microscope and LSM 3D analysis
software, Linux, Ogdensburg, NY) with a 20 air-immersion
objective lens for expression of CD11b/SMI-32 and quantification
of CD11b. To determine the morphology of microglia cells,
expression of synaptophysin and cell–cell interaction of microglia
and neurons a 63 water-immersion objective lens was used. The
LFB and the MBP covariance were measured as the pixel intensity
over a distance of 300mm in the corpus callosum. The density of
the callosal projecting axons was determined by the mean pixel
intensity on a scale from 0 to 255 of the b-tubulin III (10 squares
of 0.0214 mmxmm) in the genu of the corpus callosum with
a 63 water-immersion objective lens. TUNEL and activated
Caspase-3 positive cells were stained for NeuN and the number of
single and double positive cells was quantified per brain slide.
Confocal live imaging of microglia
Tissue of interest from cortex and corpus callosum from chronic
EAE mice 210 dpi and age-matched controls was dissected out and
sliced at a thickness of 200mm using a McIlwain tissue slicer
(Brinkman). Fluorescent staining of microglia in living brain
tissue slices was performed with Alexa 488 IB4 (Molecular Probes)
in a six-well plate with 30-mm culture plate inserts (Millipore
Coporation, Billerica, MA) by adding a stock solution to the
culture medium at a final concentration of 5 mg/ml for 60min.
Before recording, the slices were washed, transferred to a glass
bottom 30mm petri dish, covered with 200–500 ml of growth-
factor reduced matrigel (BD biosciences) and gelled at 37C
for 15min to minimize tissue motion during recording. The
movies were recorded within the first hour after the IB4 staining
was completed to avoid unspecific microglia activation, with a
confocal microscope with a 63 water-immersion objective lens
(LSM 510 Laser Scanning Microscope, Linux, Ogdensburg, NY) as
z-stacks taken every 5min for a total of 1 h (Dailey and Waite,
1999; Stence et al., 2001).
Neuronal tracing studies
Mice were deeply anaesthetized with ketamine/xylazine, then
secured in a stereotaxic mouse surgical frame (Stoelting). Callosal
projection neurons with projections to the contralateral neocortex
were labelled with hydroxystilbamidine (2% in ddH2O, Molecular
Probes), an equivalent to FluoroGold according to Molecular
Probes and previous research (Cheunsuang et al., 2006). The mice
received 20 injections in an area of 3 3mm, 50 nl per site
(craniotomy extending A/P from +1.0mm to 2.0mm from
bregma; M/L 0.5 to 3.5mm lateral to bregma; Franklin and
Paxinos, 1997). Two days after the injection of hydroxystilbami-
dine, mice were deeply anaesthetized in a CO2 chamber and
transcardially perfused with cold PBS followed by 4% cold PFA
in PBS. Brains were removed and postfixed in PFA for 48 h.
Counting of callosal projecting neurons
Forty micrometre sections were cut on a freezing microtome, and
stained for NeuN as described previously. Twenty consecutive
sections extending from bregma 0.0 to 0.8mm (Franklin and
Paxinos, 1997) were used for neuron counting. Labelled neurons
were quantified and categorized within cortical layers II/III, V and
VII. The pixel intensity of the axons in the corpus callosum was
measured over a distance of 200 mm together with the intensity
of the staining of the radiating axons extending out from the
genu of the corpus callosum. Sections were examined under
epifluorescence with a Zeiss Axioplan with high-numerical-
aperture objective lenses. Quantification of neurons was
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performed with a 40 oil-immersion objective lens, and the pixel
intensity of the corpus callosum and the radiating axons extending
out from the genu of the corpus callosum was measured with a
25 oil-immersion lens.
Statistical analysis
All data is presented as mean SEM. Statistical analysis was
performed using the unpaired, two-sided t-test comparison
between EAE and control or by using one-way analysis of
variance (ANOVA) with Turkey’s Multiple Comparison Test.
Significant differences were assumed at the 5% level and
represented as P-values (P5 0.05).
Results
Forebrain pathology in SJL mice during
EAE is reminiscent of MS pathology
SJL/J mice immunized with PLP 139-151 develop relapsing-
remitting EAE, with onset of clinical signs occurring on day
11–12 post immunization and peaking around day 17.
The mice then enter a remission phase around day 30–35
followed by several relapses and remissions (Fig. 1a). The
mice were then divided into four groups depending on the
course of disease and clinical score; acute (n= 20) average
clinical score 1.575 0.05; first remission (n= 13)
average clinical score 0.269 0.11; late relapse (n= 21)
average clinical score 2.143 0.11 and late remission
(n= 14) average clinical score 0.821 0.09 (data not
shown). On average the duration of a relapse was 33 9
days and the duration of remission was 8 4 days (data not
shown). In contrast to other models of EAE, we found a
dramatic number of lesions throughout the forebrain in the
immunized SJL/J mice (Fig. 1), with the typical perivenular
accumulation of mononuclear cells (Lassmann et al., 1981).
We found inflammatory lesions (defined as a cluster of at
least 20 mononuclear cells) correlating with cortical and
white matter (WM) pathology previously described for
MS and EAE (Peterson et al., 2001; Pomeroy et al., 2005;
Merkler, Ernsting et al., 2006; Wegner et al., 2006).
Leukocortical lesions involving both white matter and
adjacent cortical grey matter, were of variable size and
shape (diameter: 54–682 mm), and often found centred on a
vessel in cortical layer VII (Fig. 1d). Intracortical inflamma-
tory lesions were small and round or oval in shape (diameter:
65–137 mm) and were always centered on a vessel (Fig. 1e).
We also found a number of subpial lesions located in the
superficial cortical layers running parallel to the cortical
surface (Fig. 1f). These lesions could cover a very large area
(up to 1240 mm in diameter). All three types of neocortical
inflammatory lesions and WM inflammatory lesions in the
corpus callosum (Fig. 1g) were detected in all mice examined,
while few inflammatory foci were observed in CFA
immunized control mice (Fig. 1h–k). The total number of
inflammatory foci was increased 7-fold in acute animals
compared to controls and remained high throughout the
disease (all had a P5 0.05 versus control) (Fig. 1l and m).
Leukocortical lesions showed demyelination by LFB staining
in the perivascular zone filled with infiltrating cells (Fig. 2c),
but during late disease we also observed demyelinated
leukocortical lesions completely devoid of infiltrating cells
(Fig. 2e). We did not detect any demyelinated intracortical
lesions, but most of the subpial lesions were demyelinated
even during the acute disease phase (data not shown). As
expected, many of the infiltrating cells around the leukocor-
tical and intracortical lesions were positive for CD11b in EAE
mice, while few perivenular CD11b positive cells were found
in control mice (Fig. 2).
Neurofilaments in healthy myelinated axons are heavily
phosphorylated and do not stain with SMI-32 antibodies
(Sternberger and Sternberger, 1983), SMI-32 immunoreac-
tivity has therefore been used as a marker of axonal damage
in MS (Trapp et al., 1998; Peterson et al., 2001; Werner
et al., 2001) and was abundant in the cortex of mice with
EAE. Interestingly, the centre of the inflammatory lesions
contained fewer SMI-32 positive axons than the border
and the surrounding area (Fig. 2d and h). At higher
magnification small SMI-32 positive ovoids (arrowheads)
were found in close contact with activated microglia, and
transected neural elements (arrows) could be detected
around the cortical lesions (Fig. 2f’). A 3D-deconvolution
from z-stacks of cortical layer V showed extended processes
from microglial cells during acute disease highly associated
with SMI-32 positive axons, while normal-appearing
SMI-32 positive axons from control mice were not
associated with microglia (Fig. 2i and j). We also observed
satellitosis, a condition marked by an accumulation of
glia cells around a neuron, in many of the cortical
lesions (Fig. 2k and k’). Satellitosis is often a prelude to
neuronophagia (phagocytosis of nerve cells), which could
result in cell death (Song et al., 2006). These results suggest
that microglia are closely associated with SMI-32 positive
axons during disease, leading to generation of ovoids and
transected axons.
Relapsing^remitting EAE results in
persistent activation of microglia
Microglia are the resident immune effector cells of the CNS
that become activated in response to injury with dramatic
changes in their morphology as they become de-ramified
with an enlarged cell body. Research has previously
demonstrated that microglia in MS are activated even in
areas outside the inflammatory lesions (Bjartmar et al.,
2001). We found CD11b-positive microglia cells through-
out the brain both in control and EAE that were highly
abundant in the corpus callosum and cortex (Fig. 3 and
data not shown). In order to investigate the change in
activation of microglia cells at different clinical stages
of disease, we performed high-resolution scanning of 30
individual microglia cells per time point and found
that microglia in cortex were highly dynamic structures
that were able to change their morphology after
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inflammatory stimuli. The microglia in control mice had
the typical morphology of resting microglia (Stence et al.,
2001) with several very long and thin processes (Fig. 3a).
However during acute disease the microglia became
activated and developed an enlarged cell body with short
thickened processes (Fig. 3b). During the first remission
phase the microglia returned to a resting state morphology
with longer and finer processes (Fig. 3c). Interestingly, after
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Fig. 1 Immunization with PLP 139^151 results in generation of inflammatory lesions throughout the forebrain. SJL/J mice immunized with
PLP 139^151 developed relapsing^remitting EAE. (a) Representative graph of the clinical course of one EAE mouse.Onset of clinical signs
occurred at day 11 post immunization and peaked around day 17. EAE mice would then enter a remission phase followed by several relapses
and remissions. The mice were sacrificed at various time points depending on the stage of disease progression. (b)
Representative figure of inflammatory lesions (defined as a cluster of minimum 20 mononuclear cells) in the brain of an acute EAE mouse
(H&E staining). (b’) Higher magnification of montage in (b) (scale bar represents 250mm). (c) The inflammatory lesions were found in
various areas of the brain and were divided into the following three groups; (d) leukocortical, (e) intracortical and (f) subpial. There were
also a number of purely white matter inflammatory lesions (g) (scale bar d^g represents 50mm). (h^k) Scheme showing localization of
inflammatory lesions from eight individual mice; control, acute, remission and relapse (red and green represents two separate mice). (l)
The total number of inflammatory lesions per whole brain section was significantly increased at all timepoints compared with control
(acute 34 5, P5 0.05; remission 22.52.5, P5 0.05; relapse19 4, P5 0.05 versus control 3.51.5, n=4 mice/group). (m) When divided
into the three subgroups, the number of leukocortical lesions (acute 5.5 0.5, P5 0.01; remission 4.0 0.0, P5 0.01; relapse 3.0 0.0,
P5 0.01 versus control 0.5 0.5), the number of intracortical lesions (acute 7.52.5, P5 0.01; remission 5.51.5, P5 0.05; relapse 43,
P5 0.01 versus control 21) and the number of subpial lesions (acute 8 0, P5 0.01; remission 4 0, P5 0.05; relapse 4.51.5, P5 0.05
versus control 0.5 0.5) was significantly increased at all time points compared to control (n=4 mice/group).
Fig. 2 SJL mice develop cortical pathology during EAE. (a) Control mice show a fine pattern of myelination in the corpus callosum (LFB),
(b) and show very little perivenular staining for SMI-32 (red) and CD11b (green) (vessel is indicated with v). (c) Infiltrating cells and
demyelination were found around a leukocortical vessel in EAE mice and (d) had a high infiltration of CD11b microglia/macroghages (green)
together with an increase in SMI-32 staining (red). (e) Leukocortial lesion with persistent demyelination (indicated with red arrowheads)
during late relapse. (f) The leukocortical lesions were found at the border of the corpus callosum and the cortical grey matter centered on
a vessel located in cortical layer VII. (f’) A higher magnification of the lesion in (d) shows ovoids (arrows), where the axons were highly
interacting with the inflammatory cells (scale bar represents 20mm). (g) Control mice show no infiltration of microglia/macrophages (green)
around vessel (v) in cortical layer II/III and low SMI-32 staining (red). (h) Perivenular intracortical infiltrations in EAE mice have a high
content of CD11b microglia/macroghages (green) together with an increase SMI-32 staining (red) (vessel is indicated with v, scale bar in b, d,
g andh represents 50mm). 3D-deconvolution of z-stacks shows contact between CD11b positive microglia/macrophages (green) and SMI-32
positive axons (red) around vessels in acute EAE (j) but not in control mice (i) (scale bar in i and j represents 10mm). (k) Periventricular
intracortical lesion (LFB) during acute EAE with (k’) satellitosis showing infiltrating cells (red arrows) in very close contact with a neuron
(N) (scale bar in k and k’ represents 20 and 5mm).
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the first relapse the microglia remained activated with an
enlarged cell body and thicker shorter branches, with little
change in their morphology even when the disease entered
another remission or relapse (Fig. 3d and e). A similar
change in morphology was observed for microglia in
the corpus callosum (data not shown). The number of
microglia in the corpus callosum and cortex was signifi-
cantly increased during acute EAE and throughout the
disease (Fig. 3f and data not shown). These data suggest
that microglia become activated in acute EAE and may
return to a resting state in the first remission, but with
repeated bouts of inflammation they become persistently
activated, a finding reminiscent of what has been described
in chronic MS (Kutzelnigg et al., 2005).
Persistent microglia activation is
independent of T-cell infiltration
We enumerated infiltrating cells from the cortex and corpus
callosum after dissecting these areas and isolating the
cells at different time points during the disease. We found
that the percentage of CD4 cells in cortex was signifi-
cantly increased during acute disease compared to control
(6.27 0.2 versus 1.02 0.3, P5 0.0001), however the
percentage of CD4 cells decreased rapidly with time
(Fig. 3g). CD4 and CD8 cells in the corpus callosum and
CD8 cells in cortex also showed a transient increase in
percentage during acute disease compared to controls
followed by a steady decrease (data not shown). These
results were confirmed by immunofluorescence staining for
CD4 and CD8 in corpus callosum and cortex (data not
shown). CD45 and CD11b has been suggested as markers
for distinguishing between resting and activated microglia
(Stevens et al., 2002), since resting microglia express low
levels of CD45 and CD11b while activated microglia and
macrophages express high levels of these surface markers.
During acute disease (day 12), a population of highly
activated CD45hi, CD11bhicells (presumably macrophages)
was readily apparent. This population decreased by day 70
and 170, but the resident microglia started to express higher
levels of CD45, which was evident when looking at the
mean fluorescence intensity (MFI) of CD45 for the total
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Fig. 3 Persistent activation of microglia during EAE. (a) In the control cortex, the microglia had several long fine branches; (b) in acute
disease the microglia had an enlarged cell body with several short, thickened processes. (c) In the first remission phase the microglia
returned to a resting state with longer, finer branches. (d) In the late relapse, the microglia were re-activated and remained so in the
late remission phase (e) (scale bar in a^e represents 20mm). (f) The number of CD11b-positive cells in a 2-mm block of the cortex was
significantly increased throughout disease compared to control (acute 700 58.63, P=0.0001; first remission 468.8 59.84, P=0.0034;
late relapse 600 53.03, P=0.0002 and late remission 462.5 78.06, P=0.0109 versus control 20526.69, n=3 mice/group). (g) Graph
showing the average percentage of CD4+ cells in a CD45+ population in cortex.The percentage of CD4+ cells in cortex was significantly
increased during acute disease (acute 6.270.2% versus control 1.02 0.3%, P5 0.001, n=3 mice/group). (h) The mean fluorescence
intensity of CD45 in the total CD11b population in cortex increases with time (Control, 173.0 6.5; day 12, 195.0 5.0; day 70, 181.52.5
and day 170, 254.514.5, n=3 mice/group).
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CD11b population from both cortex (Fig. 3h) and corpus
callosum (data not shown). In contrast, resting microglia
express low levels of CD45 and CD11b. These results
suggest that EAE results in a transient increase of
infiltrating T cells in the forebrain which is in contrast to
the persistent microglia activation.
Immunized SJL mice develop lesions in
cortical layers II/III,Vand VII
To examine which cortical layers were most affected by the
infiltrating microglia we correlated the CD11b expression
with different neuronal markers that are known to be
expressed in specific cortical layers. Ctip2 is believed to play
a critical role in the development of corticospinal motor
neurons axonal projections (Arlotta et al., 2005; Molyneaux
et al., 2005) and is used as a marker for cortical layer V.
Cux-2 is expressed in layers II-IV of the cortex, and may
have an important role in determining the neural fate of
the upper cortical layers (Nieto et al., 2004). CTGF is only
expressed on layer VII neurons, where it is thought to play
an important regulatory role in modulating synaptic input
to apical pyramidal neurons (Heuer et al., 2003), while
MeCP2 may be involved in maturation and maintenance
of neurons (Kishi and Macklis, 2004) and is expressed in
neurons throughout the cortical layers. The expression of
Cux-2, Ctip2, CTGF and MeCP2 was unaffected by the
cortical pathology in EAE when compared to controls by
measuring single cell pixel intensity (data not shown and
Fig. 4). In control mice, resting microglia were detected
throughout the cortex but did not show significant
interaction with the neurons (Fig. 4). In contrast, during
EAE clusters of activated microglia were found mostly
associated with layers II/III, V and VII in close contact with
the neurons and surrounding the neuronal cell body with
their processes as shown by the 3D reconstruction of
confocal imaging (Fig. 4). Activated microglia at 210 dpi
were found to be very dynamic structures and their
processes exhibited increased movement and interactions
compared to the resting microglia when examined by time
lapse confocal live imaging in brain slices (Supplementary
Fig. 1 and Supplementary Movie 1).
Synaptic pathology in relapsing^remitting
EAE correlates with the presence of
activated microglia
Previous studies have demonstrated synaptic pathology
with reduced immunoreactivity for synaptophysin in spinal
cord of acute and chronic models of EAE (Zhu et al., 2003;
Marques et al., 2006), and in leukocortical MS lesions
(Wegner et al., 2006). Synaptophysin is a synaptic protein
localized on the membrane of synaptic vesicles (Zhu et al.,
2003) and it has been suggested that microglia in cortical
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Fig. 4 Immunized SJL mice develop lesions in cortical layers II/III, V and VII. (a) MECP2 immunohistochemistry shows localization of
cortical layer II/III, V and VII (scale bar represents 100mm). (b) In EAE, Cux-2 positive neurons in layer II/III, MeCP2 positive neurons in layer
V and CTGF positive neurons in layer VII were found in the same cortical layers as those affected by clusters of activated CD11b
infiltrating cells. Direct interaction of microglia and the neuronal cell body is marked by white arrows on images shown as orthogonal-view.
Cux-2, MeCP2 and CTGF positive neurons were also present in control mice, however, no microglia were found to be interacting with
these cells (scale bar represents 25mm, and 10mm for orthogonal view).
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lesions target synaptic terminals, leading to functionally
impaired neurons (Peterson et al., 2001). Alternatively,
functionally impaired neurons exhibiting weak synaptophy-
sin staining may trigger microglia activation. We assessed
synaptophysin immunoreactivity qualitatively and quantita-
tively during acute EAE in relation to microglia activation.
Synaptophysin immunostaining in control mice showed
a punctate staining that encircled the neurons. In mice
with acute disease, the staining was weak reflecting the
low density of neuronal synapses in cortical layer II/III, V
and VII correlating with high microglia content (Fig. 5a).
Interestingly, normal-appearing synaptophysin positive
neurons were not surrounded by microglia, but neurons
with weak synaptic staining were closely associated with
activated microglia (Fig. 5b). Quantification of the pixel
intensity of synaptophysin shows a reduced signal in EAE
compared to control (Fig. 5c). This suggests a relationship
between activated cortical microglia and stripping of
synaptic proteins in cortical neurons.
Since axonal transection and inflammation may cause
neuronal death (Blinzinger and Kreutzberg, 1968; Peterson
et al., 2001), we evaluated the occurrence of apoptosis
at various time points by a combination of TUNEL
and neuronal immunocytochemistry. The number of
TUNEL-positive cells was significantly increased during
acute EAE (EAE 68.33 8.4 versus control 2.67 1.3,
P5 0.05, Supplementary Fig. 2a). Apoptosis was confirmed
by activated caspase-3 staining (acute 118.0 6.5 versus
control 7.00 1.5, P5 0.001) (Supplementary Fig. 2b).
However, among over one thousand TUNEL-positive cells,
no TUNEL-positive neurons or activated caspase-3-positive
neurons were detected at any of the time points investigated
in EAE mice but instead the TUNEL-positive and the
activated caspase-3-positive cells were in most cases
found in close proximity to neurons (Supplementary
Fig. 2c–e). These data suggest that in spite of cortical
inflammation, axonal abnormalities and synaptic stripping,
neuronal apoptosis does not play a role in the observed
pathology.
Relapsing^remitting EAE results in severe
demyelination of the corpus callosum
The corpus callosum plays a central role in inter-
hemispheric communication and callosal atrophy in MS
patients was shown to correlate with disability status
(Martola et al., 2006). In four separate experiments, LFB
and MBP staining intensity was reduced in the corpus
callosum in all EAE mice, and the integrity of the myelin
fibers was compromised. Rarefaction of myelin was most
severe in the medial part of the corpus callosum, adjacent
to the lateral ventricle (LFB staining is shown in Fig. 6b
and c) where the transparency of the pixel intensity of LFB
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Fig. 5 Synaptic pathology in EAE correlates with close proximity of microglia. (a) Immunostaining with synaptophysin and CD11b
shows decreased staining for synaptophysin during EAE and highly increased CD11b expression throughout the cortex (scale bar
represents 15mm). (b) Synaptophysin immunostaining shows typical punctuated staining in the neuron cell body but not the nucleus (scale
bar represents 5mm). (c) Quantification of the pixel intensity of synaptophysin in cortical neurons showed a significantly reduced signal
in EAE mice compared to controls, also shown as a high-resolution quantitative 2.5-dimensional image of a representative neuron from
control and EAE cortical layer V, maximal synaptophysin intensity is represented in red colour.
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was increased in acute EAE due to loss of signal
(P5 0.0001 versus control, Fig. 6d) and in late relapse
(P5 0.0001 versus control, Fig. 6e) consistent with loss of
myelin. This was confirmed by myelin staining
(Supplementary Fig. 3a–h) that also showed a significant
decrease in the average MBP pixel intensity for all
four EAE groups combined compared to the average
control group (P5 0.0001, Supplementary Fig. 3m).
The rarefaction of myelin was associated with a decreased
staining of the radiating axons extending out from the
genu of the corpus callosum (Fig. 6b’ and c’). The severity
of the white matter tissue damage was graded as 3 (the
remaining fibres were disorganized and vacuoles were
frequently observed) as previously described (Wakita et al.,
1994). Since we found persistent demyelination throughout
the corpus callosum and increased interaction of microglia
in the cortex, we analysed the dynamics of microglia in
the corpus callosum. We performed live imaging of brain
slices of the corpus callosum during the chronic phase
210 dpi. We found that the microglia were increased
in size with more elongated and highly dynamic
processes, even after several months of chronic disease
(Supplementary Fig. 4 and Movie 2). These behaviours
were not seen in controls, suggesting that at the time of
active demyelination and injury, the microglia persisted in
a highly dynamic state that contrasted with the decreased
T-cell presence in similar areas during the chronic
phase (Fig. 3).
Decreased retrograde labelling of
callosal projecting neurons in
relapsing^remitting EAE
Focal lesions and diffuse axonal loss are common in MS.
Post-mortem analysis of MS tissue showed more than 50%
reduction of the total number of transcallosal axons
compared to controls (Evangelou et al., 2000). We injected
the retrograde tracer hydroxystilbamidine into one hemi-
sphere in order to examine cortical neurons contralateral
to the injection (Mitchell and Macklis, 2005; Cheunsuang
et al., 2006). Cortical layers II/III, V and VII in mice with
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Fig. 6 Relapsing^remitting EAE results in demyelination of the corpus callosum. (a) Normal myelin staining in the corpus callosum in
control mice, and a larger magnification (a’) shows the fine branches of the radiating axons (arrows) extending out from the genu of
the corpus calosum. (b and c) Rarefaction of myelin was observed in the corpus callosum of EAE mice during acute and the late relapse.
(b’ and c’) This was associated with the disruption of corona radiata (arrows) (scale bar represent 100mm). (d and e) Quantification of
demyelination by measuring the transparency of LFB staining over a distance of 300mm (white line) through the corpus callosum.There
was a significant reduction of the myelin signal in acute EAE (acute 88.510.5 versus control 20.69 0.3, P5 0.0001, n=3 mice/group)
seen as an increase in the transparency (d) and also in late relapse (late relapse 87.28 0.7 versus control 20.69 0.3, P5 0.0001, n=3
mice/group) (e).
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late relapsing EAE had significantly fewer retrogradely
labelled neurons compared with control mice (all had
P50.001 versus control, Fig. 7). The loss of callosal
projecting neurons correlated with a decrease in staining
intensity of the radiating axons extending out from the
genu of the corpus callosum (Fig. 8a) and a significant
reduction in transcallosal axons (Fig. 8b and c). The pixel
intensity of the hydroxystilbamidine staining in the
corpus callosum was significantly reduced by 50% in EAE
compared with control at 100 dpi (data not shown) and was
persistent at 250 dpi (53.19 0.3776 versus 100.4 0.51,
P5 0.0001) (Fig. 8d). These findings were consistent in two
separate experiments done in a total of 12 mice. Since a
decrease in retrogradely labelled neurons could be due to
impaired axonal transport or to axonal transection, we
measured axonal density at the genu of the corpus callosum
by immunofluorescence staining of b-tubulin III and
obtained the mean pixel intensity by confocal microscopy
during acute and late relapse compared with controls. We
found a 25% reduction in pixel intensity of transcallosal
axons during the acute phase and 15% reduction during
late relapse (data not shown). These data suggest that the
decreased retrograde labeling of callosal projecting neurons
can be attributed only partly to a loss of transcallosal axons
but a significant impact is mediated by impaired axonal
transport.
Discussion
Developing therapeutic strategies that target chronic
progression in MS is an important and unfulfilled goal of
MS treatment. For that goal to be achieved, we need to gain
insight into the molecular pathology of MS progression
and to model such therapeutic options experimentally
(Compston, 2006; Gold et al., 2006). EAE is a useful animal
model for MS but it is often criticized for the lack of
correlation with MS pathology. Recent data in marmoset
EAE has documented axonal pathology and cortical
demyelination (Villoslada et al., 2000; Pomeroy et al.,
2005; Merkler, Boscke et al., 2006), both of which are
important aspects of MS pathology, however issues of
feasibility and cost make the mouse model more suitable
for studies of chronic progression than the marmoset
model. Therefore an important question is to identify
mouse strains susceptible to cortical pathology. EAE has
been extensively studied in SJL mice but although it was
reported that inflammatory infiltrates were present at all
CNS anatomic levels, the focus has predominantly been on
the spinal cord pathology (Brown and McFarlin, 1981;
Sobel et al., 1990; Muller et al., 2000). Here we report that
the SJL mouse immunized with PLP peptide 139–151
develops extensive forebrain pathology. We show cortical,
periventricular subcortical and callosal lesions characterized
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Fig. 7 Decreased retrograde labeling of callosal projecting neurons in relapsing^remitting EAE. (a) Images showing retrograde
labeling with hydroxystilbamidine of callosal projection neurons contralateral to the injection site in control and EAE mice. Double staining
with NeuN reveals a decrease in the number of double positive neurons in cortical layers II/III,V and VII in EAE when compared to control
(scale bar represent 20mm). (b ^d) Percentage of NeuN positive neurons that are retrogradely labelled contralateral to the injection site.
The percentage was significantly decreased in EAE compared with control both at 100 and 250dpi in layer II/III (b) (EAE100 29.941.859
versus control100 69.67 3.572, P5 0.001 and EAE250 12.69 2.136 versus control250 63.652.081, P5 0.001), in layer V (c) (EAE100
20.001.981 versus control100 75.543.010, P5 0.001 and EAE250 11.631.211 versus control250 84.443.938, P5 0.001) and in layer VII
(d) (EAE100 15.751.961 versus control100 49.38 3.656, P5 0.001 and EAE250 16.44 2.934 versus control250 31.82 2.796, P5 0.001)
(n=2 mice/group).
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by demyelination, profound microglial activation and
dysfunctional cortical neurons with axonal alterations in
the corpus callosum.
Cortical lesions with demyelination and axonal altera-
tions have been reported in MS (Peterson et al., 2001;
Kutzelnigg et al., 2005) and subcortical dementia is a
feature of the disease (Martola et al., 2006). Brain
atrophy is strongly associated with disease progression
(Filippi et al., 2003; Martola et al., 2006), and may underlie
potential alterations in projecting pathways. In this
relapsing–remitting SJL model, we found profound func-
tional alterations in specific cortical projecting neurons
associated with chronic microglia activation. Microglia
remain active during the chronic phase even during remis-
sion, in contrast to T-cell infiltration, which was limited to
the acute phase. These data suggest that during the chronic
phase of EAE inflammation is sustained by microglia,
similar to the recent observations in MS tissue (Kutzelnigg
et al., 2005). The microglia extend their processes around
the cell bodies of neighbouring neurons, correlating with a
loss of synaptic proteins. Although synaptic stripping may
have a protective function in neurons (Trapp et al., 2007),
the available data in EAE and other models of neuro-
degeneration suggest that it is deleterious (Zhu et al., 2003;
Marques et al., 2006; Yoshiyama et al., 2007), moreover our
retrograde labeling data suggest that axonal transport is
altered in these projecting neurons in addition to the
axonal loss in the corpus callosum.
We did not observe neuronal apoptosis in this study, but
it is possible that rapid phagocytosis by microglia prevents
the observation of apoptotic bodies and may become more
apparent only when the neuronal apoptosis is increased
(Li et al., 2003). However, alterations of synaptic function
and axonal transport indicate that these neurons are
dysfunctional, which is consistent with evidence that
neuronal dysfunction is more prevalent that neuronal
apoptosis in MS (Whitney et al., 1999; Black et al., 2000;
Ibrahim et al., 2001; Lock et al., 2002; Ge, Gonen et al.,
2004; Ge, Law et al., 2004; Lindberg et al., 2004; Jasperse
et al., 2007; Phillips, 2007). Neuronal dysfunction char-
acterized by alterations in gene expression of synaptic
proteins and molecules important for neuronal stability,
has been documented in normal-appearing white matter
(NAWM) in MS (Lindberg et al., 2004) and EAE in the
B6 MOG 35–55 model (Zhu et al., 2003), and in a rat
model of EAE where alterations in gene expression in
cerebral cortex, hippocampus and basal forebrain was
associated with cognitive deficits (D’Intino et al., 2005).
In our study the loss of retrograde labelling with
preservation of NeuN-positive cells supports the concept
of dysfunction, through axonal loss, axonal transection and
decreased axonal transport.
Activated microglia appear to play a role in progression
of neurological diseases (Kutzelnigg et al., 2005; Yoshiyama
et al., 2007). Resting microglia survey the brain paren-
chyma, as shown by live imaging microscopy, and respond
with directed migration to laser ablation injury
(Nimmerjahn et al., 2005). However, the dynamics of
microglia during chronic injury are unclear. Here we show
that during chronic EAE there is increased microglia
surveillance and interaction with surrounding cells together
with persistent activation. Inhibition of persistent microglia
activation may prolong the life span of the mice in models
of neurodegeneration (Heppner et al., 2005; Adams et al.,
2007; Qin et al., 2007; Yoshiyama et al., 2007). Clearly a
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Fig. 8 Decreased retrograde labelling of corpus callosum axons
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better understanding of the distinct phases and molecules
that mediates microglia activation is needed since microglia
may have a different function during the acute phase of
activation than during chronic disease (Cardona et al.,
2006). For example, ablation of early activated microglia
worsens stroke suggesting that acute activation may
have a protective role (Davalos et al., 2005).
Through immunofluorescence and live imaging we have
shown that activated microglia are not only found around
inflammatory lesions but also in the normal appearing
white and grey matter. Globally activated microglia have
previously been demonstrated in NAWM for MS patients
with axonal loss but preserved myelin (Bjartmar et al.,
2001) and also in other animal models where the activated
microglia were found far from the lesions (Yoshiyama et al.,
2007). It is thought that small clusters of activated
microglia precede the occurrence of inflammatory lesions.
The mechanism of activation is presumably through
diffusion of proinflammatory cytokines. Martiney et al.
demonstrated that EAE could be suppressed by a macro-
phage-inactivating agent that inhibits the production of
proinflammatory cytokines (Martiney et al., 1998).
An important goal in studying MS is to establish models
that go beyond the modulation of T cells responses with
new endpoints such as the preservation of synaptic proteins
and axonal and neuronal function. Our observations
demonstrate a novel alteration in neuronal projecting
pathways in EAE that can help the study of molecular
mechanisms of progression and evaluation of new strategies
to stop neurodegeneration in MS.
Supplementary material
Supplementary material is available at Brain online.
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